monocrotaline has been researched along with liquiritigenin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hao, Z; Hu, F; Huang, Z; Ji, L; Sheng, Y | 1 |
| Chen, M; Huang, Z; Ji, L; Zhang, J; Zhao, Q | 1 |
2 other study(ies) available for monocrotaline and liquiritigenin
| Article | Year |
|---|---|
Liquiritigenin and liquiritin alleviated MCT-induced HSOS by activating Nrf2 antioxidative defense system.
Topics: Animals; Antioxidants; Flavanones; Glucosides; Hepatic Veno-Occlusive Disease; Hypolipidemic Agents; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Docking Simulation; Molecular Structure; Monocrotaline; NF-E2-Related Factor 2; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2018 |
Liquiritigenin and liquiritin alleviated monocrotaline-induced hepatic sinusoidal obstruction syndrome via inhibiting HSP60-induced inflammatory injury.
Topics: Adenosine Triphosphate; Animals; Anti-Inflammatory Agents; Chaperonin 60; Flavanones; Glucosides; Hepatic Veno-Occlusive Disease; Liver; Male; Mice; Mitochondria; Monocrotaline; Rats, Sprague-Dawley; RAW 264.7 Cells; Reactive Oxygen Species | 2019 |